AYYAN widens 2023 loss to SAR 216.3M; Q4 at SAR 71.9M

18/04/2024 Argaam Exclusive

View other reports

Share Price

19.78
(0.52) (2.56 %)

AYYAN Investment Co. (AYYAN)

AYYAN Investment Co. reported a net loss of SAR 216.3 million for 2023, up from SAR 44.8 million a year earlier.



Financials (M)

Item 2022 2023 Change‬
Revenues 266.23 333.28 25.2 %
Gross Income 16.83 (39.58) (335.1 %)
Operating Income (57.14) (160.50) (180.9 %)
Net Income (44.77) (216.25) (383.0 %)
Average Shares 80.64 80.64 -
EPS (Riyals) (0.56) (2.68) (383.0 %)

This came despite the rise in the 2023 top line, mainly due to higher revenues from Al Salam Hospital (owned by its subsidiary, Al Salam Medical Services Co.) as the hospital was opened in October 2022. This is besides strong revenues from Al-Ahsa Hospital (owned by its subsidiary, Al Ahsa Medical Services Co.) during the same year.

 

However, the company posted a high cost of revenues as a percentage of revenues, besides soaring general and administrative expenses. This is in addition to increased selling and marketing expenses and financing costs, alongside lower dividends.

 

AYYAN also reported a decline in share of income from an associate company.

 

In Q4 2023, net losses widened to SAR 71.9 million, from SAR 29.7 million in the prior-year period.

 

The fourth-quarter losses increased by 27.4% from SAR 56.4 million in the previous quarter.



Current Quarter Comparison (M)

Compared With The
Item Q4 2022 Q4 2023 Change‬
Revenues 56.64 93.71 65.5 %
Gross Income (29.09) (5.33) 81.7 %
Operating Income (30.30) (36.53) (20.5 %)
Net Income (29.71) (71.88) (142.0 %)
Average Shares 80.64 80.64 -
EPS (Riyals) (0.37) (0.89) (142.0 %)

Total shareholders’ equity, after minority interest, decreased to SAR 500 million as of Dec. 31, 2023, from SAR 735.73 million a year earlier.

 

Accumulated losses reached SAR 258.02 million at the end of the current period, representing 32% of the company's capital.

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.


Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.